- Report
- February 2026
- 288 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 373 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 277 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 341 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 385 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 553 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 396 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 497 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 383 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 373 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 141 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 176 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 565 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 283 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 476 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 673 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 676 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 392 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 475 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 284 Pages
Global
From €5124EUR$5,850USD£4,447GBP

Biomanufacturing is a sub-sector of biotechnology that focuses on the production of biopharmaceuticals, medical devices, and other products derived from living organisms. It involves the use of biotechnology processes such as genetic engineering, cell culture, and fermentation to produce these products. The biomanufacturing market is driven by the increasing demand for biopharmaceuticals, medical devices, and other products derived from living organisms. This demand is driven by the growing prevalence of chronic diseases, the increasing aging population, and the need for more effective treatments.
The biomanufacturing market is highly competitive, with a number of companies offering a range of products and services. Some of the major players in the market include Amgen, Merck, Novartis, Pfizer, and Roche. Other companies in the market include AbbVie, AstraZeneca, Biogen, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more